Qaisar Tanveer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Qaisar Tanveer has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
Aisha Khatoon
Department of Pathology, University of Agriculture Faisalabad, Pakistan
3 shared publicationsBilal Murtaza
School of Bioengineering, Dalian University of Science and Technology, Dalian, China
3 shared publicationsAshiq Ali
Department of Histology and Embryology, Shantou University Medical College, Shantou, China
2 shared publicationsKaynaat Akbar
Department of Zoology, Wildlife and Fisheries, Faculty of Sciences, University of Agriculture, Faisalabad 38040, Punjab, Pakistan
2 shared publications- Zhongjing Su
Department of Histology and Embryology, Shantou University Medical College, Shantou 515041, China
2 shared publications Ziyi Ji
Department of Histology and Embryology, Shantou University Medical College, Shantou, China
2 shared publications
Latest Publications
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Gene Therapy
- Vol. 25 (5) , 627-645
Molecular Insights into RNA Modifications and Their Role in Shaping Immune Responses and Tumor Microenvironments
RNA modifications play crucial roles in immune system development and function, with dynamic changes essential for diverse cellular processes. Innovative profiling technologies are invaluable for understanding the significance of these modifications in immune cells, both in healthy and diseased states. This review explores the utility of such technologies in uncovering the functions of RNA modifications and their impact on immune responses. Additionally, it delves into the mechanisms through which aberrant RNA modifications influence the tumor microenvironments immune milieu. Despite significant progress, several outstanding research questions remain, highlighting the need for further investigation into the molecular mechanisms underlying RNA modification's effects on immune function in various contexts.
- 1 October 2025
- Published by Bentham Science Publishers Ltd. in Current Gene Therapy
- Vol. 25 (5) , 627-645
Molecular Insights into RNA Modifications and Their Role in Shaping Immune Responses and Tumor Microenvironments
RNA modifications play crucial roles in immune system development and function, with dynamic changes essential for diverse cellular processes. Innovative profiling technologies are invaluable for understanding the significance of these modifications in immune cells, both in healthy and diseased states. This review explores the utility of such technologies in uncovering the functions of RNA modifications and their impact on immune responses. Additionally, it delves into the mechanisms through which aberrant RNA modifications influence the tumor microenvironments immune milieu. Despite significant progress, several outstanding research questions remain, highlighting the need for further investigation into the molecular mechanisms underlying RNA modification's effects on immune function in various contexts.
- Open Access
- 30 July 2025
- Published by Elsevier in Bone Reports
- Vol. 26, 101863
Osteoblasts sense extracellular levels of phosphate to control the local expression of phosphatases for matrix mineralisation
- 30 July 2025
- Published by Elsevier in Bone Reports
- Vol. 26, 101863
Open AccessOsteoblasts sense extracellular levels of phosphate to control the local expression of phosphatases for matrix mineralisation
- 1 February 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 208, 104644
Immune watchdogs: Tissue-resident lymphocytes as key players in cancer defense
- 1 February 2025
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 208, 104644
Immune watchdogs: Tissue-resident lymphocytes as key players in cancer defense
- Open Access
- 13 December 2023
- Published by Taylor & Francis in RNA Biology
- Vol. 21 (1) , 127-144
Therapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention
Antisense transcription, a prevalent occurrence in mammalian genomes, gives rise to natural antisense transcripts (NATs) as RNA molecules. These NATs serve as agents of diverse transcriptional and post-transcriptional regulatory mechanisms, playing crucial roles in various biological processes vital for cell function and immune response. However, when their normal functions are disrupted, they can contribute to human diseases. This comprehensive review aims to establish the molecular foundation linking NATs to the development of disorders like cancer, neurodegenerative conditions, and cardiovascular ailments. Additionally, we evaluate the potential of oligonucleotide-based therapies targeting NATs, presenting both their advantages and limitations, while also highlighting the latest advancements in this promising realm of clinical investigation.Abbreviations: NATs- Natural antisense transcripts, PRC1- Polycomb Repressive Complex 1, PRC2- Polycomb Repressive Complex 2, ADARs- Adenosine deaminases acting on RNA, BDNF-AS- Brain-derived neurotrophic factor antisense transcript, ASOs- Antisense oligonucleotides, SINEUPs- Inverted SINEB2 sequence-mediated upregulating molecules, PTBP1- Polypyrimidine tract binding protein-1, HNRNPK- heterogeneous nuclear ribonucleoprotein K, MAPT-AS1- microtubule-associated protein tau antisense 1, KCNQ1OT- (KCNQ1 opposite strand/antisense transcript 1, ERK- extracellular signal-regulated kinase 1, USP14- ubiquitin-specific protease 14, EGF- Epidermal growth factor, LSD1- Lysine Specific Demethylase 1, ANRIL- Antisense Noncoding RNA in the INK4 Locus, BWS- Beckwith-Wiedemann syndrome, VEGFA- Vascular Endothelial Growth component A.
- 13 December 2023
- Published by Taylor & Francis in RNA Biology
- Vol. 21 (1) , 127-144
Open AccessTherapeutic potential of natural antisense transcripts and various mechanisms involved for clinical applications and disease prevention
Antisense transcription, a prevalent occurrence in mammalian genomes, gives rise to natural antisense transcripts (NATs) as RNA molecules. These NATs serve as agents of diverse transcriptional and post-transcriptional regulatory mechanisms, playing crucial roles in various biological processes vital for cell function and immune response. However, when their normal functions are disrupted, they can contribute to human diseases. This comprehensive review aims to establish the molecular foundation linking NATs to the development of disorders like cancer, neurodegenerative conditions, and cardiovascular ailments. Additionally, we evaluate the potential of oligonucleotide-based therapies targeting NATs, presenting both their advantages and limitations, while also highlighting the latest advancements in this promising realm of clinical investigation.Abbreviations: NATs- Natural antisense transcripts, PRC1- Polycomb Repressive Complex 1, PRC2- Polycomb Repressive Complex 2, ADARs- Adenosine deaminases acting on RNA, BDNF-AS- Brain-derived neurotrophic factor antisense transcript, ASOs- Antisense oligonucleotides, SINEUPs- Inverted SINEB2 sequence-mediated upregulating molecules, PTBP1- Polypyrimidine tract binding protein-1, HNRNPK- heterogeneous nuclear ribonucleoprotein K, MAPT-AS1- microtubule-associated protein tau antisense 1, KCNQ1OT- (KCNQ1 opposite strand/antisense transcript 1, ERK- extracellular signal-regulated kinase 1, USP14- ubiquitin-specific protease 14, EGF- Epidermal growth factor, LSD1- Lysine Specific Demethylase 1, ANRIL- Antisense Noncoding RNA in the INK4 Locus, BWS- Beckwith-Wiedemann syndrome, VEGFA- Vascular Endothelial Growth component A.
- Open Access
- 9 November 2022
- Published by Elsevier in European Urology Open Science
- Vol. 45, S59
Upregulated FOXO 1 & 3 down regulate the tumour suppressor HOXB13, HOXB3, CHEK2, SPOP, RB1 genes in prostate cancer
- 9 November 2022
- Published by Elsevier in European Urology Open Science
- Vol. 45, S59
Open AccessUpregulated FOXO 1 & 3 down regulate the tumour suppressor HOXB13, HOXB3, CHEK2, SPOP, RB1 genes in prostate cancer